The Holmesburg Prison skin experiments scandal represents one of the darkest chapters in American medical history. Between 1951 and 1974, University of Pennsylvania dermatologist Dr. Albert Kligman conducted unethical medical experiments on approximately 300 mostly Black inmates at Holmesburg Prison in Philadelphia. These experiments involved testing pharmaceuticals, chemicals, and biological agents on vulnerable incarcerated individuals without proper informed consent. In this comprehensive guide, I will explain what happened at Holmesburg Prison, who was responsible, the devastating impact on victims, and why this scandal continues to matter in 2026.
When I first learned about these experiments, I was shocked by the scale of the ethical violations. The story involves major institutions, corporate giants, and a medical researcher who saw incarcerated human beings as nothing more than test subjects. Understanding the Holmesburg Prison skin experiments scandal is essential for anyone interested in medical ethics, racial justice, and the protection of human rights.
Table of Contents
- What Were the Holmesburg Prison Experiments
- Dr. Albert Kligman and the Retin-A Connection
- Victims and Long-Term Impact
- Timeline of Key Events
- Apologies and Institutional Accountability
- Comparison to Other Medical Experimentation Scandals
- Ethical Violations and Lessons for Medical Ethics
- FAQ: Common Questions About the Holmesburg Prison Experiments
- What happened at Holmesburg Prison?
- Who was Dr. Albert Kligman?
- When did the Holmesburg Prison experiments take place?
- What were the Holmesburg Prison experiments?
- Why did Philadelphia apologize for the experiments?
- How many inmates were affected by Holmesburg experiments?
- What was Retin-A’s connection to Holmesburg Prison?
- What were the ethical violations at Holmesburg Prison?
- Conclusion
What Were the Holmesburg Prison Experiments
The Holmesburg Prison experiments were a series of medical tests conducted on incarcerated individuals at Holmesburg Prison in Philadelphia, Pennsylvania. Dr. Albert Kligman, a dermatologist affiliated with the University of Pennsylvania, began these experiments in 1951 and continued them for 23 years until 1974. During this time, hundreds of prisoners were exposed to a wide range of substances and procedures.
The experiments were extraordinarily varied and dangerous. Inmates were subjected to dermatological testing where patches containing chemicals, viruses, and fungi were applied to their skin. Some experiments involved exposure to dioxin, the toxic chemical component of Agent Orange. Others tested asbestos, sulfuric acid, carbonic acid, and various psychotropic drugs. Microwave radiation experiments were conducted, and pharmaceutical trials tested numerous unproven medications.
Corporate sponsorship played a major role in funding these experiments. Johnson & Johnson, Dow Chemical, the U.S. Army, and numerous other organizations paid for access to this captive population. The financial incentives were substantial for all parties involved. Dr. Kligman received millions in research funding, while prisoners received as little as $1 to $3 per experiment.
Prisoners volunteered for these experiments primarily out of economic desperation. Many needed money for bail, legal fees, or basic commissary items. A significant portion of the test subjects were awaiting trial and had not been convicted of any crime. Many were illiterate and could not read the consent forms they were asked to sign. The power imbalance between the researchers and the incarcerated participants made true informed consent impossible.
The experiments took place in a dedicated testing facility within the prison. Inmates would line up to have patches applied to their backs and arms. Some experiments caused immediate reactions including burning, blistering, and severe pain. Others had delayed health effects that manifested years later. The range of testing was staggering, from seemingly innocuous skin creams to dangerous chemical exposures.
Dr. Albert Kligman and the Retin-A Connection
Dr. Albert Montgomery Kligman was a University of Pennsylvania dermatologist who became both celebrated and notorious for his work at Holmesburg Prison. Born in 1916, Kligman had a long career at Penn, where he was a faculty member for decades. He died in 2010, leaving behind a complicated legacy that includes significant medical advances and grave ethical violations.
Kligman’s most famous contribution to medicine was the co-invention of Retin-A, the acne medication that revolutionized dermatological treatment. He patented Retin-A in 1967, and it was subsequently licensed to Johnson & Johnson. The medication became one of the most successful pharmaceutical products in history, generating billions of dollars in revenue. Kligman earned substantial royalties from the patent, making him wealthy while the prisoners who helped test the drug received minimal compensation.
The connection between Retin-A and Holmesburg Prison is direct and troubling. Kligman tested early formulations of Retin-A and other retinoid compounds on Holmesburg inmates. The prisoners served as human guinea pigs for pharmaceutical development. Their skin reactions, tolerance levels, and side effects were carefully documented to perfect the medication before it went to market.
Perhaps the most infamous quote associated with Kligman came when he first saw the prison population. He reportedly exclaimed, “All I saw before me were acres of skin.” This statement reveals his view of the inmates as nothing more than experimental material. It demonstrated a profound dehumanization of the incarcerated individuals who would become his test subjects for over two decades.
Kligman defended his work throughout his life, arguing that the prisoners consented and benefited financially. He maintained that the research was valuable and that the participants were willing volunteers. However, critics point out that the power dynamics of incarceration, the illiteracy of many participants, and the economic coercion made true consent impossible. The American Medical Association and numerous ethics experts have since condemned his methods.
The University of Pennsylvania supported Kligman’s research for decades. He remained on faculty until 1987 and maintained emeritus status until his death. Penn only distanced itself from Kligman after public pressure mounted in the 2000s, when journalist Allen Hornblum’s book “Acres of Skin” brought widespread attention to the scandal.
Victims and Long-Term Impact
The victims of the Holmesburg Prison experiments were predominantly Black men, reflecting the racial demographics of the incarcerated population in Philadelphia during that era. While exact numbers remain difficult to determine, approximately 300 inmates were part of a lawsuit filed in 2000, though hundreds more likely participated over the 23-year period. The victims also included some incarcerated women, an often-overlooked aspect of the scandal.
Herbert Rice, one of the victims who spoke publicly about his experience, described horrific treatment. “They put some kind of radiation on my back in four places,” he recalled. “When my skin came back it was like leather.” Rice and others describe lifelong physical scars, chronic pain, and ongoing health issues that they attribute to their participation in the experiments.
Female inmates at Holmesburg were also subjected to experimentation, though this aspect of the scandal received less attention. Some women reported being tested with substances that affected their reproductive health and hormonal balance. One survivor described feeling “less than a woman” after her participation, highlighting the profound psychological impact alongside physical harm.
The long-term health consequences for victims have been severe and varied. Many participants developed chronic skin conditions, including persistent rashes, scarring, and abnormal pigmentation. Others report autoimmune disorders, respiratory problems, and various cancers that they believe are linked to chemical exposures. The psychological trauma has been equally devastating, with many survivors experiencing anxiety, depression, and PTSD symptoms.
Generational trauma has affected the families of victims as well. Children and grandchildren of Holmesburg survivors report that their family members never fully recovered from the physical and psychological wounds inflicted during the experiments. The economic exploitation, receiving only a few dollars while others profited millions, added insult to injury that still resonates decades later.
Allen Hornblum, who documented the scandal in his book “Acres of Skin,” captured the essence of the tragedy. “They were really lab rats in every sense of the word,” he wrote, “but they were human beings who were powerless.” This powerlessness, combined with racial discrimination and economic exploitation, created perfect conditions for abuse.
Timeline of Key Events
Understanding the Holmesburg Prison skin experiments scandal requires examining the chronological development of events. The timeline spans over seven decades, from the initial experiments in the 1950s to institutional apologies in the 2020s.
1951: Dr. Albert Kligman begins conducting experiments on inmates at Holmesburg Prison. He partners with the University of Pennsylvania and begins securing corporate contracts for pharmaceutical and chemical testing.
1967: Kligman patents Retin-A, which would become one of the most profitable acne medications in history. Much of the testing for this drug occurred on Holmesburg inmates.
1974: Philadelphia Mayor Frank Rizzo bans all non-therapeutic experimentation on prison inmates in the city. This ends the Holmesburg experiments after 23 years of operation.
1998: Allen Hornblum publishes “Acres of Skin: Human Experiments at Holmesburg Prison,” bringing widespread public attention to the scandal for the first time. The book documents the experiences of victims and the ethical violations in detail.
2000: Approximately 300 former Holmesburg inmates file a lawsuit against the University of Pennsylvania, Dr. Kligman (who died before trial), and various corporate entities involved in the experiments.
2002: The lawsuit is dismissed due to the statute of limitations. The court rules that too much time had passed since the experiments occurred for legal action to proceed. Victims receive no compensation.
2021: University of Pennsylvania Medicine issues a formal apology for its role in the Holmesburg Prison experiments. The institution acknowledges its ethical failures and the harm caused to vulnerable individuals.
October 2022: The City of Philadelphia, led by Mayor Jim Kenney, issues a formal apology for the experiments conducted at Holmesburg Prison. The apology acknowledges the racial injustice and medical racism inherent in the program.
January 2023: The College of Physicians of Philadelphia issues an apology for not speaking out against the experiments when they were occurring. The organization acknowledges that silence constituted complicity.
2026: Advocacy continues through groups like the Philadelphia Inmate Justice Coalition, pushing for further acknowledgment, compensation for victims’ families, and educational efforts to prevent similar abuses.
Apologies and Institutional Accountability
The institutional response to the Holmesburg Prison scandal has been slow and incomplete. While several major organizations have issued formal apologies, many victims and advocates feel these apologies came too late and offered too little.
The City of Philadelphia’s apology in October 2022 was significant as the first formal acknowledgment from the municipality. Mayor Jim Kenney stated, “While this happened many decades ago, we know that the historical impact and trauma of this practice of medical racism has extended for generations.” The apology came as part of a broader racial reckoning in the city following the murder of George Floyd and nationwide protests.
University of Pennsylvania Medicine apologized in 2021, acknowledging that Dr. Kligman’s experiments violated fundamental ethical principles. The institution admitted that it had failed to protect vulnerable populations and had allowed research that exploited power imbalances. However, critics noted that Penn had honored Kligman throughout his lifetime and only distanced itself after public pressure mounted.
The College of Physicians of Philadelphia issued perhaps the most meaningful apology in January 2023. Unlike Penn and the city, the College had no direct involvement in the experiments. However, they acknowledged that their silence during the 1950s-1970s constituted complicity. Their statement that “silence is complicity” resonated with victims who had felt ignored by the medical establishment for decades.
Corporate accountability remains largely absent. Johnson & Johnson, which licensed Retin-A and profited enormously from it, has never formally apologized for its role in testing the drug on prisoners. Dow Chemical, which funded dioxin and chemical exposure experiments, has similarly avoided acknowledgment. Neither company has offered compensation to victims or their families.
The U.S. Army, which funded various experiments at Holmesburg including chemical agent testing, has also avoided formal acknowledgment. Military involvement in prison experimentation extended beyond Holmesburg to other facilities, suggesting a systemic pattern that has never been fully investigated or addressed.
Victim response to the apologies has been mixed. While many appreciate the acknowledgment of wrongdoing, they note that apologies without compensation feel hollow. Leodus Jones Jr., son of a Holmesburg victim, has been vocal in demanding that institutions put resources behind their words. The Philadelphia Inmate Justice Coalition continues advocating for concrete actions including educational initiatives, memorialization efforts, and financial restitution.
Comparison to Other Medical Experimentation Scandals
The Holmesburg Prison experiments did not occur in isolation. They fit into a disturbing pattern of unethical medical experimentation in the United States, particularly targeting vulnerable and marginalized populations. Understanding these connections provides important context for the scale of the problem.
The most frequently cited comparison is the Tuskegee Syphilis Study, conducted between 1932 and 1972 by the U.S. Public Health Service. Researchers withheld treatment from Black men with syphilis to study the disease’s progression, even after penicillin became available. Both Tuskegee and Holmesburg targeted Black populations, lacked genuine informed consent, and were conducted by respected medical institutions. However, Holmesburg involved active experimentation with dangerous substances rather than withholding treatment.
The Guatemala syphilis experiments, conducted by U.S. researchers in the 1940s, involved deliberately infecting Guatemalan prisoners, soldiers, and mental patients with sexually transmitted diseases without consent. Like Holmesburg, these experiments exploited captive populations in other countries.
During World War II, the U.S. military conducted numerous experiments on soldiers, including mustard gas exposure and malaria studies. While these involved ostensibly voluntary military personnel, the power dynamics of military hierarchy raise similar consent concerns.
Prison experimentation was not limited to Holmesburg. Throughout the mid-20th century, numerous American prisons hosted medical research programs. The Willowbrook State School experiments on mentally disabled children, the Jewish Chronic Disease Hospital cancer cell injections, and various CIA-funded MKUltra projects all demonstrate a systemic disregard for vulnerable human subjects.
What distinguishes Holmesburg is its duration (23 years), scale (hundreds of inmates), corporate involvement (multiple major companies), and the commercial success of products tested there (particularly Retin-A). While other scandals ended when exposed, Holmesburg continued until a political decision by Philadelphia’s mayor finally halted the program.
Ethical Violations and Lessons for Medical Ethics
The Holmesburg Prison experiments violated fundamental principles of medical ethics that were established even during the time they were conducted. The Nuremberg Code of 1947, created in response to Nazi medical experiments, explicitly required voluntary consent for human experimentation. Yet Kligman and his sponsors proceeded for decades without adhering to these standards.
The most egregious violation was the absence of genuine informed consent. True informed consent requires that participants understand what they are agreeing to, including potential risks and benefits, and that they can refuse without negative consequences. At Holmesburg, many participants were illiterate and could not read consent forms. Economic coercion meant that refusing meant losing money needed for bail or basic necessities. The power imbalance between free researchers and incarcerated subjects made voluntary participation impossible.
Racial targeting constituted another major ethical violation. The experiments specifically targeted Black inmates, reflecting both the racial demographics of incarceration and deliberate exploitation of a vulnerable population. This racial dimension transforms the ethical violations into civil rights violations as well.
Corporate and institutional accountability failures allowed the abuse to continue. The University of Pennsylvania, various pharmaceutical companies, and government agencies all funded or facilitated experiments they knew or should have known were unethical. The profit motive, both for Kligman through Retin-A royalties and for companies seeking cheap testing, overrode ethical concerns.
The scandal contributed to significant reforms in human subjects research. The National Research Act of 1974 created the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Institutional Review Boards (IRBs) became mandatory for research involving human subjects. Prison experimentation was severely restricted or banned in many jurisdictions.
Modern medical ethics education frequently uses Holmesburg as a case study in what not to do. Medical students learn about informed consent, vulnerable population protection, and institutional oversight through examining these failures. However, the fact that similar abuses continue in various forms globally suggests that vigilance remains essential.
FAQ: Common Questions About the Holmesburg Prison Experiments
What happened at Holmesburg Prison?
Between 1951 and 1974, University of Pennsylvania dermatologist Dr. Albert Kligman conducted unethical medical experiments on approximately 300 mostly Black inmates at Holmesburg Prison in Philadelphia. Experiments included testing dermatological products, exposing inmates to dioxin, asbestos, viruses, fungi, and various chemical agents. Prisoners received minimal compensation ($1-3 per experiment) and many lacked proper informed consent. The scandal became public through Allen Hornblum’s 1998 book ‘Acres of Skin.’
Who was Dr. Albert Kligman?
Dr. Albert Montgomery Kligman (1916-2010) was a University of Pennsylvania dermatologist who conducted experiments at Holmesburg Prison for 23 years. He co-invented Retin-A, the acne medication that became highly profitable. Kligman is infamous for viewing inmates as ‘acres of skin’ and conducting dangerous experiments on vulnerable incarcerated individuals. He defended his work until his death, though institutions have since condemned his ethical violations.
When did the Holmesburg Prison experiments take place?
The Holmesburg Prison experiments occurred from 1951 to 1974, spanning 23 years. Dr. Kligman began testing on inmates in 1951, and the experiments continued until Philadelphia Mayor Frank Rizzo banned all non-therapeutic prison experimentation in 1974. Public exposure came in 1998 with the publication of Allen Hornblum’s book ‘Acres of Skin.’ Institutional apologies were issued between 2021 and 2023.
What were the Holmesburg Prison experiments?
The experiments included dermatological testing (applying chemicals, viruses, fungi to skin), exposure to dioxin (Agent Orange component), asbestos testing, pharmaceutical trials for drugs including Retin-A, microwave radiation exposure, and testing of psychotropic substances. Corporate sponsors included Johnson & Johnson, Dow Chemical, and the U.S. Army. Inmates received patches on their backs and arms, with some experiments causing immediate burns and others creating long-term health problems.
Why did Philadelphia apologize for the experiments?
Philadelphia apologized in October 2022 because the experiments represented unethical medical racism and exploitation of vulnerable populations. Mayor Jim Kenney acknowledged that while the experiments occurred decades ago, the trauma extended through generations. The apology was part of broader racial reckoning efforts following the George Floyd protests. The city recognized its complicity in allowing medical experimentation on mostly Black inmates without proper consent.
How many inmates were affected by Holmesburg experiments?
Approximately 300 inmates were part of a 2000 lawsuit against the University of Pennsylvania and related entities, though the total number of participants over 23 years likely reached several hundred. The majority were Black men, though some incarcerated women were also subjected to experimentation. Exact numbers are difficult to determine due to incomplete record-keeping.
What was Retin-A’s connection to Holmesburg Prison?
Dr. Kligman co-invented Retin-A and tested early formulations on Holmesburg inmates. He patented the acne medication in 1967, and Johnson & Johnson licensed it. The drug became one of the most successful dermatological products in history, generating billions in revenue and substantial royalties for Kligman. Prisoners who helped develop and test Retin-A received only a few dollars in compensation while others profited enormously from their suffering.
What were the ethical violations at Holmesburg Prison?
Major ethical violations included lack of informed consent (many prisoners were illiterate), economic coercion (desperate need for bail money), racial targeting (mostly Black inmates), dangerous substance exposure without adequate safety protocols, exploitation of vulnerable incarcerated populations, institutional failure to protect human subjects, and commercial profiting from prisoner suffering. These violations directly contradicted the Nuremberg Code established in 1947.
Conclusion
The Holmesburg Prison skin experiments scandal stands as a stark reminder of what happens when medical research prioritizes profit over human dignity. For 23 years, hundreds of mostly Black inmates suffered exploitation, dangerous testing, and lifelong health consequences while institutions and corporations profited from their pain.
Understanding the Holmesburg Prison skin experiments scandal explained in this guide reveals uncomfortable truths about medical racism, institutional complicity, and the vulnerability of incarcerated populations. The apologies issued in recent years by Philadelphia, the University of Pennsylvania, and the College of Physicians represent important acknowledgment of wrongdoing, but they cannot undo the suffering inflicted.
As we continue into 2026, the legacy of Holmesburg serves as a crucial case study in medical ethics education and a warning against the dehumanization that enables such abuses. The victims deserve to be remembered not as “acres of skin” but as human beings whose rights were violated by a system that failed to protect them.